QUEBEC CITY, Aug. 8, 2012 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the “Company”) will announce its second quarter 2012 financial and operating results after market close on Tuesday, August 14, 2012. The Company will host a conference call on the following day, Wednesday, August 15, 2012, at 8:30 a.m. (Eastern Time), to discuss these results, provide an update on the Company’s business and discuss expectations for the future.
Participants may access the live webcast via the Company’s website at www.aezsinc.com in the “Newsroom” section, or by telephone using the following numbers: in Canada, 514-807-9895 or 647-427-7450, outside Canada, 888-231-8191. A replay of the webcast will also be available on the Company’s website for a period of 30 days.
About Aeterna Zentaris
Aeterna Zentaris is an oncology and endocrinology drug development company currently investigating treatments for various unmet medical needs. The Company’s pipeline encompasses compounds at all stages of development, from drug discovery through to marketed products. For more information, please visit www.aezsinc.com.
SOURCE AETERNA ZENTARIS INC.